Literature DB >> 19837285

Clostridium perfringens vaccines.

Richard W Titball1.   

Abstract

Both Clostridium perfringens spores and toxins have reportedly been considered as a biological warfare agents. The spores may be incorporated into weapons which cause traumatic injury, and the resulting delivery of spores deep into tissues would result in the development of gas gangrene. Of the C. perfringens toxins, the epsilon-toxin is of particular concern and now appears on the list of CDC select agents. Currently there are no licensed vaccines suitable for use in humans which protect against either gas gangrene or epsilon-toxin. However, vaccines being developed for use in animals have the potential to be developed for use in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837285     DOI: 10.1016/j.vaccine.2009.07.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.

Authors:  Jingjing Kang; Jie Gao; Wenwu Yao; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Jiahao Yao; Wenwen Xin; Baohua Zhao; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-17       Impact factor: 3.452

2.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

Review 3.  Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis.

Authors:  Evy Goossens; Bonnie R Valgaeren; Bart Pardon; Freddy Haesebrouck; Richard Ducatelle; Piet R Deprez; Filip Van Immerseel
Journal:  Vet Res       Date:  2017-02-16       Impact factor: 3.683

Review 4.  Toxins as biological weapons for terror-characteristics, challenges and medical countermeasures: a mini-review.

Authors:  Tamar Berger; Arik Eisenkraft; Erez Bar-Haim; Michael Kassirer; Adi Avniel Aran; Itay Fogel
Journal:  Disaster Mil Med       Date:  2016-04-29

5.  Evaluation of plant-produced <i>Clostridium perfringens</i> type D <i>epsilon</i> toxoid in a vaccine against enterotoxaemia in sheep.

Authors:  Tinyiko Mokoena; Ereck Chakauya; Michael Crampton; Boet Weyers; Malefa Tselanyane; Tsepo Tsekoa; Rachel Chikwamba
Journal:  Onderstepoort J Vet Res       Date:  2017-04-25       Impact factor: 1.792

6.  Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin.

Authors:  Xuwen Gao; Yingying Ma; Zhuo Wang; Jing Bai; Shuo Jia; Baohua Feng; Yanping Jiang; Wen Cui; Lijie Tang; Yijing Li; Li Wang; Yigang Xu
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

Review 7.  Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?

Authors:  Bradley G Stiles; Gillian Barth; Holger Barth; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2013-11-12       Impact factor: 4.546

8.  Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.

Authors:  Gustavo Marçal Schmidt Garcia Moreira; Felipe Masiero Salvarani; Carlos Eduardo Pouey da Cunha; Marcelo Mendonça; Ângela Nunes Moreira; Luciana Aramuni Gonçalves; Prhiscylla Sadanã Pires; Francisco Carlos Faria Lobato; Fabricio Rochedo Conceição
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

9.  Immunization with a novel Clostridium perfringens epsilon toxin mutant rETX(Y196E)-C confers strong protection in mice.

Authors:  Wenwu Yao; Jingjing Kang; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Wenwen Xin; Jinglin Wang
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

10.  Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.

Authors:  Rina Fujiwara-Tani; Kiyomu Fujii; Shiori Mori; Shingo Kishi; Takamitsu Sasaki; Hitoshi Ohmori; Chie Nakashima; Isao Kawahara; Yukiko Nishiguchi; Takuya Mori; Masayuki Sho; Masuo Kondoh; Yi Luo; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.